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Introduction Giardiasis is an intestinal diarrhoeal illness caused by the flagellate protozoan 
parasite Giardia intestinalis. Molecular techniques for the identification of Giardia 
intestinalis have generally been shown to offer a better detection rate of the parasite than the 
traditional faecal concentration and microscopy techniques.  
Aim The aim of this study was to critically assess the performance of a commercial and a 
published real-time PCR assay for their potential use as frontline tests for the diagnosis of 
giardiasis.  
Methods A composite reference standard of enzyme immunoassay and rapid membrane test 
was used in a diagnostic accuracy study to assess the performance of Primerdesign Ltd. and 
Verweij et al. (2004) Giardia intestinalis real-time PCR assays comparing them with the 
traditional ova, cysts, and parasite microscopy test (OCP-M). 
Results The Verweij real-time PCR used primers for the (SSU) rRNA gene and produced a 
diagnostic sensitivity of 93.4 % (95 % CI: 88.30 to 98.50 %) and an efficiency of 100 %. The 
Primerdesign Ltd. real-time PCR used primers for the glutamate dehydrogenase gene and 
produced a diagnostic sensitivity of 61.5 % (95 % CI: 51.50 to 71.50 %) and an efficiency of 
203 %. The OCP-M sensitivity was 83.5 % (95 % CI: 75.87 to 91.13 %). 
Conclusions The Verweij real-time PCR was robust and the most sensitive assay suited for 
use as a first line diagnostic test for giardiasis. 
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1. INTRODUCTION  
Giardiasis is an intestinal diarrhoeal illness caused by the flagellate protozoan parasite 
Giardia intestinalis (synonymous with Giardia lamblia and Giardia duodenalis). 
Traditionally, faecal concentration technique described by Allen and Ridley 
1-2
 has been used 
to  diagnose Giardiasis. Faecal concentration and microscopy techniques are cumbersome and 
rely heavily on the expertise of the person reading the slides. However, it is considered to be 
the gold standard for the diagnosis of giardiasis, even though it has relatively low sensitivity. 
Sensitivity has been reported to increase from 73 % to 85 % when multiple samples taken on 
different days were examined.
3
 Molecular-based assays for the detection of Giardia 
intestinalis have been shown to be more sensitive than conventional methods. 
4-8
 However, 
their amplification efficiency (E) and correlation coefficient (linearity, R
2
) have not been 
critically assessed for use in routine diagnosis. In this study, the Verweij et al. (2004) real-
time PCR assay which targets the (SSU) rRNA gene,
8
 and the Primerdesign Ltd. real-time 
PCR which targets the glutamate dehydrogenase gene (gdh) of Giardia assemblages A and B 
only (the subtypes known to infect humans), were compared with the traditional ova, cysts, 
and parasite microscopy (OCP-M) in a diagnostic accuracy study. The performances of the 




2. MATERIALS AND METHODS  
2.1 Samples  
Stool samples (n = 213), from patients with suspected gastrointestinal infection, submitted for 
testing were archived from 30th March 2010 to 22nd July 2011 after performing the 
traditional faecal concentration technique (Parasep, DiaSys Europe Ltd.) on them. Before 
archiving, the faecal concentrates were examined microscopically using the x10 objective, 
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followed by the x40 objective with the application of a drop of iodine to aid in the 
identification of internal structures of cysts. When unformed or liquid stools were 
encountered, direct wet preparations and methanol fixed, rapid Field’s (TCS Biosciences) 
stained faecal smears were also prepared to supplement the spun deposit to look for 
trophozoites of Giardia intestinalis. The samples comprised 98 Giardia intestinalis 
microscopy positive samples and 115 microscopy negative samples. Each sample was split 
and stored at 4-6 °C and at -20 °C to preserve the integrity of cysts for subsequent re-
examination and the stability of parasite DNA and antigens for molecular studies. Forty three 
samples were excluded as they dried up in storage before testing began and repeated samples 
from the same patient were also discounted. One-hundred and seventy samples remained 
after applying the exclusion criteria. 
2.2 Conventional methods 
The samples were divided into true positive (TP) and true negative (TN) cases using a 
composite reference standard (CRS) of enzyme immunoassay (EIA), Techlab Giardia II, and 
a single one-step immunochromatographic membrane assay, Coris Giardia strip rapid 
membrane test (RMT). The manufacturers’ recommended procedures were followed to test 
these samples blindly. The combined results of the EIA and the RMT defined four criteria for 
the determination of TP and TN cases (Table 1). 
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Enzyme Immunoassay(EIA) Rapid Membrane Test(RMT) 
1 P  or WP N TP 10 
2 N P or WP TP 2 








P = Positive, WP = Weak positive, N = Negative, TP = True positive, TN = True negative. 
 
2.3 Molecular methods 
2.3.1 Extraction of DNA 
DNA was extracted from 0.5 g of stool (500 µl when liquid) using a modified QIAamp DNA 
Mini kit protocol for tissue extraction. The tissue DNA extraction kit was chosen instead of 
the QIAamp DNA stool mini kit because, under these conditions, it yields higher quantities of 
parasite DNA and is more amenable to high throughput sample processing.
9
 Prior to 
extraction, each sample was supplemented with a standardized quantity of Escherichia coli 
transformed with a green fluorescent protein (GFP) gene to serve as the extraction and 
internal control
10
 together with the extraction control provided by Primerdesign Ltd. in the 
Giardia intestinalis PCR kit.  
7 
2.3.2 Real-time PCR assay 
The Verweij et al. (2004) real-time PCR primers and probe set consisted of forward primer 
Giardia-80F and reverse primer Giardia-127R,  and the Giardia intestinalis-specific double-
labelled probe Giardia-105T (Biolegio, Malden, The Netherlands) (Table 2).  
The primers were used at a final concentration of 400 nM each for the forward and reverse 
primers and 120 nM for the probe in 25 µl reactions containing 5 µl templates DNA. 
Amplification was performed in a Rotor-Gene Q 6000 (Corbett Life Sciences) using 
TaqMan(R) Environmental Master Mix 2.0 (Applied Biosystems). The cycling conditions 
were: 95 
o
C (10 min), 95 
o
C (15 s), 60 
o
C (60 s) for 45 cycles. 
 
Table 2: Oligonucleotide primers and probes for real-time and conventional PCR assays for 
the detection of Giardia intestinalis 
Target organism: Name of primers and probes                                                  Oligonucleotide sequence 5’ – 3’ 
Real-time PCR 
G. intestinalis  
Giardia-80F                                                                                                               5’-GACGGCTCAGGACAACGGTT-3’ 
Giardia-127R                                                                                                                   5’-TTGCCAGCGGTGTCCG-3’ 
Giardia-105T                                                                                         5’CY5-CCCGCGGCGGTCCCTGCTAG-3’BHQ2 
Conventional PCR 
RH 11                                                                                                                           5'-CATCCGGTCGATCCTGCC-3' 
RH 4,                                                                                                                     5'-AGTCGAACCCTGATTCTCCGCCAGG-3' 
GiarF:                                                                                                                          5'-GAC GCT CTC CCC AAG GAC-3' 
GiarR:                                                                                                                          5'-CTG CGT CAC GCT GCT CG-3' 
 
A cycle threshold (CT) was assigned to a sample for each channel when its normalised 
fluorescence exceeded 0.1 units. Samples with a CT of ≤ 40 were deemed positive for G. 
intestinalis DNA. Samples with a CT of greater than 40 or with no CT were called negative 
only when their GFP CT values were below the run average for GFP CT values plus 1.23. 
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This is the value determined as the optimal cut off for a 5 % rejection rate through the 
analysis of multiple runs within the laboratory (data not shown). For negative samples whose 
GFP CT exceeded this value, the sample was repeated with a 1 in 10 dilution according to 
internal validation criteria to examine the effect of PCR inhibitors. Any diluted sample whose 
CT was greater than the run mean plus 5 CT was considered a technical failure, requiring re-
extraction and re-amplification. The Primerdesign Ltd. assay did not have such a stringent 
criteria for determining positivity. According to the manufacturer’s instructions (Genesig 
Advanced kit handbook, HB10.03.03), CT values of 31±3 are within the normal range for the 
internal extraction control, and any outside this range were treated as run failures and re-
extracted and re-amplified.  
2.3.3 Conventional single round PCR 
The real-time PCR primer pairs, Giardia-80F and Giardia-127R, were used but 
without the probe in a conventional PCR amplification and analysis by gel-electrophoresis for 
the 62 bp amplicons of Giardia intestinalis to investigate apparent false positive samples. A 
G-Storm Thermocycler (Kapa Biosystems Model GS00001) was used with the following 
protocol: heated lid 110 
o
C; hot start 1 cycle for 95 min and 15 min; 95 
o
C (45 s) and 60
 o
C 
(90 s) repeated for a total of 45 cycles; 72 
o
C for 1 cycle followed by a holding temperature 
of 10 
o
C. The amplification protocol was repeated with the same set of primers as a two step 
reaction to maximize the yield of 62 bp amplicons for potential sequencing.  
2.3.4 Conventional nested PCR 
Conventional nested PCR was run to investigate further apparent false positive 
results. The nested PCR used two different sets of primers to amplify a 130bp fragment of the 
Giardia intestinalis (SSU) rRNA gene for visualization using gel electrophoresis 
11
. In the 
nest 1 reaction, the RH11/RH4 primers (Table 2) amplified a 292-bp region of the 5' end of 
the (SSU) rRNA gene. The PCR amplification was performed in 25 µl volumes with the final 
9 
mix containing 5-50 ng DNA as per published method 
12
 using Biomix red (Bioline product). 
The amplification process consisted of 1 cycle at 95 
o
C (2 min); 94 
o
C (20 s), 59 
o
C (20 s), 
and 72
 o
C (30 s) repeated for a total of 40 cycles; 72 
o
C (7 min) for 1 cycle. The nest 2 
primers which amplified 130 bp fragment were: GiarF and GiarR
13
 (Table 2). A Thermo 
Electron Px2 thermal cycler was used with the following amplification protocol: 1 cycle at 95
 
o
C (2 min); 94
 o
C (20 s), 59
 o
C (20 s), and 72
 o
C (30 s) repeated for a total of 45 cycles; 72
 o
C 
(7 min) for 1 cycle as per published protocol using Biomix red 
12-13
. 
2.4 Analytical sensitivity and specificity 
The analytical potential of all the tests (both index and reference) deployed in this study were 
verified by the estimation of their limit of detection prior to the estimation of their diagnostic 
accuracy measures. The limit of detection (LOD) of the five assays were determined using 
DNA extracted from a serially diluted 5-fold dilutions of a Giardia-positive stool sample to 
provide the range of estimated cysts concentration of 71,000 cysts/ml to 4.6 cysts/ml of stool 
(Table 3). The diluent was a Giardia-negative stool liquefied with phosphate buffered saline 
(PBS) pH 7.2. The real-time assays were tested in triplicate. 
Analytical specificity was ascertained by using a pooled Giardia-negative stool with various 
types of parasitic, bacterial, and fungal organisms including Entamoeba coli, Endolimax 
nana, Entamoeba histolytica/dispar, Yeasts, Escherichia coli, Klebsiella sp., Citrobacter sp., 
Proteus sp. and Enterococcus faecalis, Cyclospora cayetanensis and Cryptosporidium sp. 
Bacterial pathogens were not available but had already been tested in a previous study
7
.  
2.5 Real-time PCR performance evaluation 
A set of 10-fold serial dilutions of a Giardia intestinalis DNA template solutions prepared 
from the 71,000 cysts/ml solution in Table 3 were tested in triplicate. The E and R
2 
from the 
regression lines were compared with the equivalent values generated from the 5-fold serial 
10 
dilutions used for the LOD testing. The calculation of E was based the formula E = 10(-
1/slope) – 1 for standard curve generated by a R2 of the plotted points.14  
2.6 Diagnostic accuracy 
A composite reference standard (CRS) of RMT and EIA was used in a diagnostic  
study of the three index tests (OCP-M, Verweij real-time PCR, and Primerdesign Ltd. 
Giardia real-time PCR) as recommended by the Health Technology Assessment for 
diagnostic accuracy studies when there is no gold standard.
15
 McNemar statistics was used in 
a pair wise comparison to establish the significance of any differences in the performance of 
the diagnostic tests before diagnostic accuracy measures were calculated using cross 
tabulation statistics (2x2-table): sensitivity = (number of true positives)/(number of true 
positives + number of false negatives) percent,  and specificity = (number of true 
negatives)/(number of true negatives + number of false positives) percent.
16
 Positive 
likelihood ratio (LR+) was calculated as (sensitivity)/(1 -  specificity), and negative 




3.1 Analytical sensitivity and specificity of diagnostic tests 
The 5-fold serial dilutions of Giardia intestinalis positive stool were tested in triplicate for all 
five assays. A positive result was only recorded for each assay with a given dilution when all 
three of the repeats gave a positive result (Table 3). Since all the dilutions gave a positive 
result with the Verweij assay, the LOD for this assay was estimated to be 4.6 cysts/ ml or 
lower. By comparison, the LOD for the Primerdesign Ltd. PCR was 113.6 cysts/ml. Indeed, 
apart from an isolated positive result (CT 38.9) in one of the triplicate run in 22.7 cysts/ml 
11 
tube, the Primerdesign Ltd. assay did not detect any positivity in any replicates involving less 
than 113.6 cysts/ ml.  
 
Table 3: Determination of limit of detection (LOD) using Giardia intestinalis positive stool 
sample containing 71,000 cysts/ ml. The cysts were counted using C-Chip counting chamber 
and diluted 1 in 5 down to 4.6 cysts/ ml.  
Test 


















































Keys: nt = not tested; + = positive; - = negative; RMT = Rapid Membrane Test; OCP-M = 
Ova, Cysts, and Parasite Microscopy; EIA = Enzyme Immunoassay. 
 
The RMT and the EIA formed the constituent tests for the CRS with a combined LOD of ≤ 
2,840 cysts/ml (Table 3). Analytical specificity was 100 % for each of the diagnostic tests 
evaluated as these all gave a negative result with the pooled Giardia-negative stool (Table 3).   
3.2 Diagnostic accuracy measures 
Using the four criteria listed in Table 1, the composite reference standard divided the 170 
samples into 91 true positive and 79 true negative cases and this enabled diagnostic accuracy 
measures to be estimated for the OCP-M and the two real-time PCR assays (Table 4).  
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Table 4: Delineation of true positive and true negative cases 
Index test   Composite reference standard of EIA and RMT (TP: 91, TN: 79) 
TP (TPF) FN (FNF)  TN (TNF) FP (FPF)  TP +FN+ TN+FP 
OCP-M 76 (83.5%) 15 (16.5%)  76 (96.2%) 3 (3.8%)  170 
Primerdesign 56 (61.5%) 35 (38.5%)  78 (98.7%) 1 (1.3%)  170 
Verweij 85 (93.4%) 6 (6.6%)  59 (74.7%) 20 (25.3%)  170 
TP = true positive; TN = true negative; TPF = true positive fraction; TNF = true negative fraction, FPF = false positive 
fraction; FNF = false negative fraction. 
 
McNemar test results produced p-values < 0.05 for each paired test (i.e OCP-M vs. 
Primerdesign; OCP-M vs Verweij; and Primerdesign vs Verweij) indicating significant 
differences in performance which warranted a further investigation with cross tabulation 
statistics (2x2 table) to calculate the diagnostic accuracy measures shown in Table 5. The 
Verweij assay was diagnostically more sensitivity [93.4 % (95 % CI: 88.30 to 98.50 %)] than 
the Primerdesign Ltd. assay [61.5 % (95 % CI: 51.50 to 71.50 %)] (Table 5).  
Table 5: Comparative diagnostic performance results of real-time PCR assays and the 
traditional OCP-M method for the laboratory detection of Giardia intestinalis.  
Index test Sensitivity (SN) Specificity (SP) Likelihood ratios (LR) 
SN 95 % CI SP 95 % CI LR+ 95 % CI LR- 95 % CI 
OCP-M 83.5 75.87 to 91.13  96.2 91.98 to 100.00*  22.0 13.49 to 30.51 0.17 -0.74 to 1.08 
Primerdesign 61.5 51.50 to 71.50  98.7 96.20 to 100.00*  47.3 37.04 to 57.56 0.39 -0.98 to 1.76 
Verweij 93.4 88.30 to 98.50  74.7 65.11 to 84.29 3.7 -0.18 to 7.58 0.09 -0.57 to 0.75 
LR+ = positive likelihood ratio; LR- = negative likelihood ratio; 95 % CI = 95 % confidence interval. * These values have 
been curtailed to 100 % since a specificity of greater than this value is biologically meaningless. 
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The sensitivity of the Verweij assay was affected by 20 samples recorded as false positive 
cases. When these samples were investigated with gel-electrophoresis using the same primers 
as the real-time PCR, 14 samples gave an amplicon corresponding to the expected 62 bp 




Figure 1: Conventional gel-electrophoresis analysis of Verweij real-time PCR. The figure 
shows a representative number of the 20 apparent false positive samples. Two % agarose 
was stained with Safeview and showed the results of four of the discrepant samples. 
Lanes 1 and 18 are 100 bp ladder (Gentaur); lanes 2, 3, and 5 showed diagnostic bands for 
62 bp for Giardia intestinalis representing samples 103, 12, and 104 respectively; lane 4 is 
sample no. 44 and it was negative for 62 bp Giardia intestinalis amplicon. Lanes 14 and 17 
were positive controls; lanes 15 and 16 were negative controls. (NB. lanes 6-13 were 
known Giardia intestinalis positive samples run alongside the discrepant samples on this 
gel). Sixty two bp bands were also seen on other gel (image not provided). 
 
The absence of such a fragment would have almost certainly indicated a false positive case. 
In the real-time PCR, an additional level of specificity comes from the ability of the probe to 
specifically bind to the intended 62 bp fragment; hence it is unlikely that any of the larger 
sized bands are responsible for the positive CT in these samples. Indeed, one of the 14 
samples was independently confirmed as Giardia intestinalis with 130 bp fragments when 
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as TP samples and used in a restricted comparison between the OCP-M and the Verweij real-
time PCR, the re-calculated sensitivity of 94.3 % (95 % CI: 89.87 to 98.73) for the Verweij 
real-time (Table 6) resulted in an increase of 19.3 % (94.3 % - 75 %) in the detection of 
positive cases. More importantly the specificity was increased to 90.8 % (83.77 – 97.83). 
Table 6: Adjusted diagnostic accuracy figures for OCP-M and Verweij real-time PCR 
resulting from the addition of the 14 confirmed TP cases to the CRS. Composite reference 





OCP-M Verweij real-time PCR 
% 95 % CI % 95 % CI 
Sensitivity 75 66.72 to 83.28 94.3 89.87 to 98.73 
Specificity 98.5 95.55 to 100.00* 90.8 83.77 to 97.83 
LR+ 50.0 40.44 to 59.56 10.3 4.49 to 16.11 
LR- 0.25 -0.96 to 1.46 0.06 -0.54 to 0.66 
LR+ = Positive likelihood ratio; LR- = Negative likelihood ratio; OCP-M = Ova, cysts, and parasite 
microscopy. * These values have been curtailed to 100% since a specificity of greater than this value is 
biologically meaningless. 
3.3 Real-time PCR assay performance 
The E and R
2
 for the 1 in 5 serially diluted stool samples were E = 100 % (the slope was -
3.326), R
2 
= 0.99 for the Verweij real-time PCR and E = 203 % (the slope was -2.076) and R
2
 
= 0.93 for the Primerdesign Ltd. real-time PCR. A 10-fold serial dilutions of G. intestinalis 
DNA produced an efficiency of 100 % (the slope was -3.315) and R
2
 = 0.95 with the 
Primerdesign Ltd. real-time PCR and 96.3 % (the slope was -3.414) and R
2
 = 0.99 for the 
Verweij real-time PCR, respectively. Generally efficiency between 90 % and 110 % is 
considered acceptable and an R
2
 value > 0.99 provides good confidence in correlating two 
values (Life Technologies, Real-time PCR: Understanding Ct, 2011). None of the 170 
Verweij real-time PCR reactions had an internal control CT value greater than the run mean 
15 
CT plus 1.23. Using our rejection criteria, this means than none of the samples were 
considered to show levels of inhibition that would identify the sample as a run failure. The 
Primerdesign Ltd. real-time PCR however showed 48 out of the 170 samples (28.2 %) to 
have CTs higher than manufacturer’s quoted range of 31±3.   
 
4. DISCUSSION  
The aim of this study was to use a composite reference standard (CRS) to critically 
assess the diagnostic accuracy of both OCP-M and real-time PCR methodology for use as a 
frontline test for the laboratory diagnosis of giardiasis. The failure of the OCP-M to detect 
Giardia in at least 16.5 % Giardia intestinalis positive stool samples (as determined by the 
Composite Reference Standard - CRS) may explain why symptoms highly indicative of 
chronic giardiasis (include diarrhoea and malabsorption) persist in some patients despite 
repeatedly negative stool microscopy results. Indeed, many of such patients when treated 
empirically for giardiasis using tinidazole show clinical resolution of their symptoms (data 
not shown), strongly supporting the clinical need for implementation of new diagnostic 
approaches with increased sensitivity. 
The Verweij assay has proven to be both sensitive and robust when applied to clinical 
stool samples submitted for routine diagnosis of giardiasis. The initial low specificity of the 
assay (74.7 %) compared to OCP-M (96.2 %) could be a potential draw back with the assay, 
leading to unnecessary treatment of patients for giardiasis. However, there is good evidence 
to suggest that 70 % of the Verweij real-time PCR apparent false positive cases (14/20) were 
true positives because of the presence of appropriately sized amplicons (62 bp) (Figure 1). 
These amplicons did not yield enough DNA for sequencing when they were excised and 
16 
extracted from the conventional electrophoresis gel, thus limiting our investigations to visual 
interpretation of gel images. An increased sensitivity with the Verweij assay is also supported 
by the dramatic differences in the LOD for this assay (< 5 cysts/ml), OCP-M (14,200 
cysts/ml) and CRS (≤ 2,840 cysts/ml). Re-evaluating these 14 samples as true positives gives 
a specificity of 90.8 %. The effects of the sensitivity and specificity can be seen by examining 
the likelihood ratios
18
, calculated in diagnostic accuracy studies to determine the presence or 
absence of an abnormality
17
. The lower specificity of the Verweij assay compared to OCP-M 
resulted in a decrease in LR+ of 50.0 to 10.3, meaning patients diagnosed as being positive 
are less likely to have active giardiasis. The improvement in sensitivity resulted in a reduction 
of LR- from 0.25 (achieved with OCP-M) to 0.06 (Table 6). Thus patients who are negative 
with this assay can be classified as true negatives with a far higher certainty than can be 
achieved with conventional diagnostic approaches. Tinidazole is a well-tolerated drug with 
few side effects. Using a regret theory approach to decision curve analysis, implementation of 
a diagnostic test with a very high level of sensitivity but lower level of specificity may 
therefore be associated with a far lower level of regret compared to existing diagnostics with 
higher specificity but lower sensitivity. The inclusion of these 14 likely additional true 
positive cases in the CRS would result in a 19.3 % increase in the detection of positive cases 
compared to OCP-M (Tables 6). There was only one apparent amplification failure where 
cysts were seen on microscopy but the Verweij real-time PCR failed to give a positive result 
even though the GFP extraction control was positive. The problem was most likely a 
sampling issue caused by the uneven distribution of the Giardia intestinalis parasite in the 
stool sample. The issue was resolved when the stool (study case no. 142) was re-extracted 
and the PCR repeated.  The intermittent excretion and uneven distribution of the parasite in 
faecal samples are confounding problems with stool microscopy, which a very sensitive test 
can only partially mitigate it would seem.  
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The Verweij real-time PCR did not appear to be affected by PCR inhibitors because all CTs 
for the GFP internal control were within the acceptance criteria of the mean CT plus 1.23. 
The resilience of the Verweij assay to PCR inhibition is also supported by the tight 
concordance of the efficiencies generated from DNA extracted from the stool dilution series 
and a dilution of purified G. intestinalis DNA in molecular grade water. With both of these 
standards, efficiencies remained in the acceptable range of 90-110 %. The Primerdesign PCR 
did not appear to fare so well with PCR inhibition: About 28 % of the internal control CTs for 
the Primerdesign PCR were greater than 34, the higher end of the normal range given by the 
manufacturer. This may well explain the high discrepancy between the efficiency of 
amplification achieved with the two sets of G. intestinalis DNA standards. In addition our 
data support a lower sensitivity for assays targeting the gdh gene compared to those targeting 
the (SSU) rRNA 
19-20
, suggesting an optimal downstream deployment for the Primerdesign 
PCR reserved for the molecular characterization of G. intestinalis parasites into assemblages 
or subspecies. 
Real-time PCR technology has become an appealing alternative to conventional methods for 
diagnosing infectious diseases
21
 and has already brought improvement in laboratory 
workflows and turnaround times for epidemiological typing of clinical isolates of G. 
intestinalis.
22
 A future extension of this study will be analysis of G. intestinalis genotypes 
using a multi-locus approach to explore host specificity, transmission patterns and possible 
targets for drug resistance. The increase in sensitivity offered by this technique opens up the 
possibility of using real-time PCR to monitor patients post treatment as a test of cure. Before 
this can be done, however, it will be critical to determine the length of time DNA from non-
viable G. Intestinalis can be detected in patients following successful treatment. Such work 
will also require the ability to differentiate between viable and non-viable parasites, possibly 
using reverse transcriptase PCR. 
18 
Take home messages 
1. The Verweij real-time PCR protocol with (SSU)-rRNA primers detected 
approximately 10 % more Giardia intestinalis parasites than the traditional ova, cysts, 
and parasite microscopy (OCP-M) method and 32 % more than the Primerdesign Ltd. 
real-time Giardia PCR assay. 
2. The Primerdesign Ltd. Giardia real-time PCR assay was more suited for 
epidemiological studies involving the molecular characterization of Giardia 
intestinalis into assemblages A and B. 
3. The Verweij assay was shown to be more optimised and robust in the harsh 
environment of stool samples with reaction efficiency well within the acceptable 
range of 90 – 110 % and a R2 ≥ 0.99 making it more applicable as a frontline 
diagnostic test. 
4. Likelihood ratios (LR+ and LR-) were better with the (SSU)-rRNA primers at 95 % 
CI. 
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